These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32956188)

  • 1. Diabetic Macular Edema Management in Asian Population: Expert Panel Consensus Guidelines.
    Chhablani J; Wong K; Tan GS; Sudhalkar A; Laude A; Cheung CMG; Zhao P; Uy H; Lim J; Valero S; Ngah NF; Koh A
    Asia Pac J Ophthalmol (Phila); 2020; 9(5):426-434. PubMed ID: 32956188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Corticosteroids in the Treatment of Patients With Diabetic Macular Edema Who Have a Suboptimal Response to Anti-VEGF: Recommendations of an Expert Panel.
    Regillo CD; Callanan DG; Do DV; Fine HF; Holekamp NM; Kuppermann BD; Singer MA; Singh RP
    Ophthalmic Surg Lasers Imaging Retina; 2017 Apr; 48(4):291-301. PubMed ID: 28419394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the appropriate management of diabetic macular edema: Light on DME survey and consensus document by an expert panel.
    Bandello F; Midena E; Menchini U; Lanzetta P
    Eur J Ophthalmol; 2016; 26(3):252-61. PubMed ID: 26776698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.
    Maturi RK; Glassman AR; Liu D; Beck RW; Bhavsar AR; Bressler NM; Jampol LM; Melia M; Punjabi OS; Salehi-Had H; Sun JK;
    JAMA Ophthalmol; 2018 Jan; 136(1):29-38. PubMed ID: 29127949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMPLIANCE AND ADHERENCE OF PATIENTS WITH DIABETIC MACULAR EDEMA TO INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN DAILY PRACTICE.
    Weiss M; Sim DA; Herold T; Schumann RG; Liegl R; Kern C; Kreutzer T; Schiefelbein J; Rottmann M; Priglinger S; KortUEm KU
    Retina; 2018 Dec; 38(12):2293-2300. PubMed ID: 29068914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines from an expert panel for the management of diabetic macular edema in the Malaysian population.
    Ngah NF; Muhamad NA; Mohamed SO; Abdul Aziz RA; Ma'amor NH; Ahmad Tarmidzi NA; Hashim H; Ishak H; Wan Muda WN; Muda R; Adnan A; Saleh RM; Wong HS; Mohd Jamil N; George TM; Koh A
    Int J Ophthalmol; 2023; 16(5):712-720. PubMed ID: 37206185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of intravitreal triamcinolone acetonide in diabetic macular edema refractory to anti-VEGF treatment.
    Hong IH; Choi W; Han JR
    Jpn J Ophthalmol; 2020 Mar; 64(2):196-202. PubMed ID: 31900869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yearly Treatment Patterns for Patients with Recently Diagnosed Diabetic Macular Edema.
    Moulin TA; Adjei Boakye E; Wirth LS; Chen J; Burroughs TE; Vollman DE
    Ophthalmol Retina; 2019 Apr; 3(4):362-370. PubMed ID: 31014689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
    Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
    Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
    [No Abstract]   [Full Text] [Related]  

  • 10. Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema: A Randomized, Double-Masked, Parallel-Design, Controlled Study.
    Barakat MR; Wykoff CC; Gonzalez V; Hu A; Marcus D; Zavaleta E; Ciulla TA
    Ophthalmol Retina; 2021 Jan; 5(1):60-70. PubMed ID: 32829027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical Decision Making for Treatment of Diabetic Macular Oedema with DEX Implant: a Consensus Paper].
    Augustin AJ; Feltgen N; Haritoglou C; Hoerauf H; Maier MM; Mardin CY; Schargus M
    Klin Monbl Augenheilkd; 2021 Jan; 238(1):73-84. PubMed ID: 31770786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal Layers Changes in Patients with Diabetic Macular Edema Treated with Intravitreal Anti-VEGF Agents: Long-Term Outcomes of a Spectral-Domain OCT Study.
    Chatziralli I; Kazantzis D; Theodossiadis G; Theodossiadis P; Sergentanis TN
    Ophthalmic Res; 2021; 64(2):230-236. PubMed ID: 32564022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for the management of diabetic macular oedema with intravitreal dexamethasone implant: A national Delphi consensus study.
    Kodjikian L; Baillif S; Couturier A; Creuzot-Garcher C; Delyfer MN; Matonti F; Weber M
    Eur J Ophthalmol; 2022 Sep; 32(5):2845-2856. PubMed ID: 34779302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic macular oedema treated with intravitreal anti-vascular endothelial growth factor - 2-4 years follow-up of visual acuity and retinal thickness in 566 patients following Danish national guidelines.
    Hodzic-Hadzibegovic D; Sander BA; Monberg TJ; Larsen M; Lund-Andersen H
    Acta Ophthalmol; 2018 May; 96(3):267-278. PubMed ID: 29240306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of diabetic macular edema with intravitreal dexamethasone implants: Expert recommendations using a Delphi-based approach.
    Giovannini A; Parravano M; Ricci F; Bandello F
    Eur J Ophthalmol; 2019 Jan; 29(1):82-91. PubMed ID: 29882421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expert recommendations for the management of diabetic macular edema with intravitreal dexamethasone implant: A Turkish Delphi study.
    Batıoğlu F; Yanık Ö; Saatçi AO; Eldem B; Akkın C; Afrashi F; Özdemir H; Menteş J; Güngör K; Karabaş L; Karaçorlu M; Demircan N; Koçak N; Kır N; Ünlü N; Avcı R; Arvas S; Dündar SO; Kadayıfçılar S; Kaynak S; Özdek Ş; Ovalı T
    Eur J Ophthalmol; 2023 Jan; 33(1):398-407. PubMed ID: 35924358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual Outcomes Following Intravitreal Ranibizumab for Diabetic Macular Edema in a Pro Re Nata Protocol from Baseline: A Real-World Experience.
    James DGP; Mitkute D; Porter G; Vayalambrone D
    Asia Pac J Ophthalmol (Phila); 2019; 8(3):200-205. PubMed ID: 31165603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of intravitreal dexamethasone implants in the treatment of diabetic macular edema: Expert recommendations using a Delphi approach.
    García Layana A; Adán A; Ascaso FJ; Cabrera F; Donate J; Escobar Barranco JJ; Peralta G; Reyes García R; Rodríguez Maqueda M; Ruiz-Moreno JM; Vinagre I;
    Eur J Ophthalmol; 2020 Sep; 30(5):1042-1052. PubMed ID: 31291782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of diabetic macular edema patients in clinical practice in Spain.
    Abreu-Gonzalez R; Gallego-Pinazo R; Abraldes M; Pinilla I; Lopez-Galvez MI
    Eur J Ophthalmol; 2019 Nov; 29(6):664-672. PubMed ID: 30295076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effect of combined intravitreal ranibizumab injection and sub-tenon steroid injection in the treatment of resistant diabetic macular edema.
    Eriş E; Perente I; Vural E; Vural A; Seymen Z; Celebi ARC; Erdogan G; Ozkaya A; Artunay O
    Int Ophthalmol; 2019 Jul; 39(7):1575-1580. PubMed ID: 29943100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.